2025 American Society of Clinical Oncology (ASCO)

 

 

Review video summaries and oral abstracts from Dana-Farber physician-scientists at the ASCO 2025 Annual Meeting.

ARC-20 Study Presented by Toni Choueiri, MD. Video

ARC-20 Study Presented by Toni Choueiri, MD.

Toni Choueiri, MD, of Dana-Farber Cancer Institute presents first results from the ARC-20 trial evaluating casdatifan (HIF-2 inhibitor) + cabozantinib (VEGF TKI) in metastatic clear cell kidney cancer.
Toni Choueiri, MD

Toni Choueiri, MD

Medical Oncology
TRADE Study Presented by Erica Mayer, MD. Video

TRADE Study Presented by Erica Mayer, MD.

Dr. Erica Mayer shares results from the TRADE study showing a successful abemaciclib dose escalation strategy in patients with HR+ breast cancer.
Erica Mayer, MD, MPH

Erica Mayer, MD, MPH

Institute Physician
Assistant Professor of Medicine, Harvard Medical School
ReACT 1.0 Study Presented by Glenn Hanna, MD. Video

ReACT 1.0 Study Presented by Glenn Hanna, MD.

Dr. Glenn Hanna presented phase 2 data suggesting that circulating HPV DNA could serve as a real-time biomarker to guide treatment intensity in HPV-positive oropharyngeal cancer.
Glenn Hanna, MD

Glenn Hanna, MD

Medical Oncology
Letrozole + Abemaciclib + Metformin Study Presented by Panos Konstantinopoulos, MD, PhD. Video

Letrozole + Abemaciclib + Metformin Study Presented by Panos Konstantinopoulos, MD, PhD.

Dr. Panos Konstantinopoulos presented the first study of a triplet therapy combining letrozole, abemaciclib, and metformin in any cancer type.
Panos Konstantinopoulos, MD, PhD

Panos Konstantinopoulos, MD, PhD

Medical Oncology
NSCLC Study Presented by Julia Rotow, MD. Video

NSCLC Study Presented by Julia Rotow, MD.

Dr. Julia Rotow presented results from a study using a cell-free DNA (cfDNA)-guided strategy to personalize first-line treatment for advanced non-small cell lung cancer.
Julia Rotow, MD

Julia Rotow, MD

Medical Oncology
Talazoparib + Tazemetostat Presented by Atish Choudhury, MD, PhD. Video

Talazoparib + Tazemetostat Presented by Atish Choudhury, MD, PhD.

Dr. Atish Choudhury presented clinical trial results evaluating the combination of talazoparib and tazemetostat in advanced prostate cancer.
Atish D. Choudhury, MD, PhD

Atish D. Choudhury, MD, PhD

Medical Oncology
Checkmate 214 Presented by Toni Choueiri, MD. Video

Checkmate 214 Presented by Toni Choueiri, MD.

Dr. Toni Choueiri shares groundbreaking 9-year results from the CHECKMATE-214 trial.
Toni Choueiri, MD

Toni Choueiri, MD

Medical Oncology
DESTINY-Breast09 Presented by Sara Tolaney, MD, MPH. Video

DESTINY-Breast09 Presented by Sara Tolaney, MD, MPH.

Dr. Sara Tolaney of Dana-Farber shares pivotal results from the DESTINY-Breast09 phase 3 trial.
Sara M. Tolaney, MD, MPH

Sara M. Tolaney, MD, MPH

Medical Oncology
Stereotactic Radiation Presented by Ayal Aizer, MD. Video

Stereotactic Radiation Presented by Ayal Aizer, MD.

Dr. Ayal Aizer of Dana-Farber Brigham Cancer Center presents results at #ASCO25 from a phase 3 trial on stereotactic radiation.
Ayal Aizer, MD, MHS

Ayal Aizer, MD, MHS

Medical Oncology
PRISM-AC Study Presented by Abby Rosenberg, MD, MS. Video

PRISM-AC Study Presented by Abby Rosenberg, MD, MS.

A new psychosocial intervention is showing promising results for adolescents and young adults (AYA) facing advanced cancer.
Abby Rosenberg, MA, MD, MS

Abby Rosenberg, MA, MD, MS

Medical Oncology
Colon Cancer Study Presented by Sara Char, MD. Video

Colon Cancer Study Presented by Sara Char, MD.

A new study shows that consuming an anti-inflammatory diet could extend overall survival after treatment for stage 3 colon cancer.
Sara Char, MD

Sara Char, MD

Phase 2 PROSPECT Study Presented by Lakshmi Nayak, MD. Video

Phase 2 PROSPECT Study Presented by Lakshmi Nayak, MD.

Lakshmi Nayak, MD presented results from a phase 2 PROSPECT study focused on tirabrutinib and it's effect on patients with relapsed or refractory primary central nervous system lymphoma.
Lakshmi Nayak, MD

Lakshmi Nayak, MD

Neuro-oncology

News Releases

 

Resources 

 

Events

 

Awards & Honors
  • OncLive's Giants in Cancer Care Award Recipient - Gastrointestinal Cancer: Brian M. Wolpin, M.D., MPH – Dana-Farber Cancer Institute

 

Dana-Farber Presence at ASCO 2025
  • Conducted over 40 oral abstract or clinical science symposium presentations
  • Presented more than 70 poster presentations
  • Participated in dozens of additional presentations in education sessions, special sessions or panel sessions

 

Follow us on social media